Evidence check: Glukose in the context of Darmgesundheit

The relationship between glucose and gut health is complex and increasingly studied. Elevated blood glucose levels can influence gut microbiota composition – for instance, excess simple sugars like glucose are associated with reduced microbial diversity and an overgrowth of potentially harmful bacteria (e.g., Firmicutes vs. Bacteroidetes). Animal studies suggest that high glucose intake may weaken the intestinal barrier and promote inflammatory processes. In humans, however, the evidence is largely associative; robust randomized controlled trials demonstrating a causal effect of glucose alone on gut health are lacking. Factors such as fiber intake, overall diet, and individual microbiota composition play major roles. MyBody-X does not offer a specific glucose-gut analysis; its existing tests (e.g., microbiome or DNA tests) can provide indirect clues but cannot directly measure glucose-gut interactions. For consumers, reducing added sugars and adopting a high-fiber diet are evidence-based strategies to support gut health, while specific glucose-microbiome interventions remain insufficiently validated. The evidence level is therefore mechanistic and mixed.